Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-28

Clinical Trial Update: Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate the effects of Sabroxy supplementation on insulin resistance and cognitive function in adults with mild cognitive imp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sabroxy (Oroxylum indicum extract)

Snippet

Sponsor: SF Research Institute, Inc. | Conditions: Insulin Resistance, Mild Cognitive Impairment | NA | Status: RECRUITING